Lakhasly

This Derna Academy Journal for Applied Sciences study (2023-133) investigated anemia prevalence among 80 chronic kidney disease (CKD) patients (46 female, 34 male; ages 22-85, mean 49±13). Anemia (Hb <12 g/dl in females, <13 g/dl in males) affected 65 patients (81.2%). Anemia distribution across CKD stages showed 73.8% in stage five, 15.4% in stage two, 6.2% in stage three, and 4.6% in stage one; stages zero and four had no anemic patients. The study also noted a significant reduction in mean Hb and HCT levels correlating with decreasing kidney function. Female anemia prevalence was 76.5%, while male prevalence was 84.8%.

33Derna Academy Journal for Applied Sciences (DAJAS)-Legal Filing Number (2023-133), Email: [email protected] 5:Prevalence of anemia among Chronic kidney disease (CKD) patients according to gender.Anemia andChronic kidney disease (CKD) stages Nearly three-quarters of anemic patients were in the fifth stage (73.8%), tenanemicpatients were in the second stage (15.4%), four anemic patients were in the third stage (6.2%), and three anemic patients were in the first stage (4.6%) and no patients in stages zero and four as shown in figure6.Figure6:The distribution of the anemia based on chronickidney disease (CKD) stages.4.DISCUSSIONThe results of this study showed that the ages of patients ranged from 22 to 85 years, with an average age of 49 49 ± 13 years 13 years. 23were between 20 and 39 years old (28.7%), forty were between 40 and 59 years old (50.0%), and seventeen were 60 years old (21.3%). As a result of this study, a slightly larger percentage of women than men. Of the 80 patients, 46 patients were female (57.5%) and 34 patients were male (42.5%). This also led to the prevalence of early-stage anemia being that the fourth quarter was in stage one (10.0%), the patients were in stage 0 (2.5%), there was no patient in stage four, and the majority of patients were at stage five (62.5%). Fifteen patients (18.8%) were in stage two. These rates were in the third stage (6.2%). This study concludes that the prevalence of anemia is 65 patients with anemia (81.2%), and 15 patients have a normal haemoglobin level (18.8%).76.50%23.50%84.80%15.20%0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%80.00%90.00%AnemicNormal Hemo globinMaleFemale0%4.60%15.40%6.20%0%73.80%13.30%33.30%33.30%6.80%0%13.30%0%10%20%30%40%50%60%70%80%0 StageI StageII StageIII StageIV StageV StageCKD Stages No rmal Hemoglobin
34Derna Academy Journal for Applied Sciences (DAJAS)-Legal Filing Number (2023-133), Email: [email protected] I found that it connected with a character like that, and I also found that there are people among those people who donate.Haemoglobin levels below 12 g/dl (anemia) in females were about (76.5%), while those with haemoglobin levels over 12 g/dl (normal) were about (23.5%). Figure 5 shows that, in addition, the proportion of men with haemoglobin levels below 13 g/dl (anemia) was about (84.8%), while the proportion of males with haemoglobin levels above 13 g/dl (normal) was approximately (15.2%). Nearly three-quarters of the anaemic patients were in stage five (73.8%), ten anaemic patients were in stage two (15.4%), four anaemic patients were in stage three (6.2%), and three anaemic patients were in the first stage (4.6%). We also found that the meanlevels of Hb level HCT were significantly reduced due to the gradual loss in kidney function.People with chronic kidney disease